Hirokawa Yoshimi, Kinoshita Hironori, Tanaka Tomoyuki, Nakata Katsuhisa, Kitadai Noriyuki, Fujimoto Koichi, Kashimoto Shigeki, Kojima Tsuyoshi, Kato Shiro
Chemistry Research Laboratories, Dainippon Sumitomo Pharma Co. Ltd., Enoki 33-94, Suita, Osaka, 564-0053, Japan.
J Med Chem. 2008 Apr 10;51(7):1991-4. doi: 10.1021/jm8000136. Epub 2008 Mar 11.
Although earlier pleuromutilin analogues showed potent in vitro antibacterial activity against some Gram-positive pathogens, their in vivo efficacy was low because of insufficient pharmacokinetic properties. We designed novel thioether pleuromutilin derivatives having a purine ring as a polar and water solubilizing group and identified a promising pleuromutilin analogue 6 with good solubility in water ( approximately 50 mg/mL). Compound 6 exhibited excellent in vitro and in vivo antibacterial activity against some Gram-positive strains, including drug-resistant pathogens.
尽管早期的截短侧耳素类似物在体外对某些革兰氏阳性病原体显示出强大的抗菌活性,但由于药代动力学性质不足,它们的体内疗效较低。我们设计了具有嘌呤环作为极性和水溶性基团的新型硫醚截短侧耳素衍生物,并鉴定出一种有前景的截短侧耳素类似物6,其在水中具有良好的溶解度(约50mg/mL)。化合物6对包括耐药病原体在内的一些革兰氏阳性菌株表现出优异的体外和体内抗菌活性。